{"id":14481,"date":"2025-09-26T12:41:25","date_gmt":"2025-09-26T07:11:25","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=14481"},"modified":"2025-09-26T13:34:28","modified_gmt":"2025-09-26T08:04:28","slug":"vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/","title":{"rendered":"Vijaypd Ceutical IPO Opens: Key Details Investors Shouldn\u2019t Miss"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_section el_id=&#8221;blog-inner-layout&#8221;][vc_row overlay_dotted=&#8221;&#8221;][vc_column el_class=&#8221;blog_primary&#8221;][vc_row_inner][vc_column_inner][vc_column_text css=&#8221;&#8221;]<\/p>\n<p>India\u2019s IPO market continues to grow in 2025 with a variety of companies tapping into public funding. Among them, Vijaypd Ceutical Limited offers a promising investment opportunity in the pharmaceutical distribution sector. The company is all set to launch its IPO on September 29, 2025, with \u20b919.25 crore in fresh capital, providing investors an exciting chance to be a part of this growing business.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"About_Vijaypd_Ceutical_Ltd\"><\/span><strong>About Vijaypd Ceutical Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vijaypd Ceutical Limited, incorporated in October 1971, is a well-established distributor of pharmaceutical products and consumer goods. The company acts as a distributor, stockist, agent, and supplier, catering to both the <a href=\"https:\/\/www.torusdigital.com\/stocks\/sectors\/pharmaceuticals\">pharmaceutical<\/a> and <a href=\"https:\/\/www.torusdigital.com\/stocks\/sectors\/fmcg\">FMCG<\/a> sectors. Their product portfolio includes medicines such as injections, tablets, capsules, ointments, and liquid oral products, along with vitamins, hormones, wellness tonics, serums, diagnostic test kits, personal care items, and even ayurvedic and cosmetic products.<\/p>\n<p>As of March 31, 2025, the company serves over 2,100 pharmacies, clinics, and nursing homes across four districts in India, covering 20 locations. Vijaypd Ceutical collaborates with over 170 healthcare product manufacturers, offering access to over 19,000 SKUs. The company\u2019s certifications from the FDA, FSSAI, and BMC ensure high standards in its operations.<\/p>\n<p>The company\u2019s commitment to providing high-quality products and its expansive distribution network position it as a strong player in the growing pharmaceutical market.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Strengths\"><\/span><strong>Competitive Strengths:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>Strong relationships with clients and partners<\/li>\n<li>Extensive and diversified product portfolio<\/li>\n<li>Streamlined supply chain management<\/li>\n<li>Experienced management with proven execution capabilities<\/li>\n<\/ul>\n<p><a href=\"https:\/\/torusdigital.go.link\/hgQeE\" target=\"_blank\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/07\/Desktop-1.jpg\" alt=\"\" class=\"responsive-img\" \/><br \/>\n<\/a><\/p>\n<style>\n  .responsive-img {\n    display: block;\n    margin-left: auto;\n    margin-right: auto;\n    width: 100%;\n    max-width: 900px;\n<\/style>\n<h2><span class=\"ez-toc-section\" id=\"Vijaypd_Ceutical_IPO_Details\"><\/span><strong>Vijaypd Ceutical IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <a href=\"https:\/\/www.torusdigital.com\/ipo\/vijaypd-ceutical-ltd-ipo\">Vijaypd Ceutical IPO<\/a> is a fixed price issue amounting to \u20b919.25 crore. The entire issue consists of 0.55 crore shares with an issue price of \u20b935 per share. The IPO is set to open for subscription on September 29, 2025, and close on October 1, 2025.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"IPO_Timeline\"><\/span><strong>IPO Timeline:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Event<\/strong><\/td>\n<td><strong>Date (Tentative)<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>IPO Open Date<\/td>\n<td>Sep 29, 2025<\/td>\n<\/tr>\n<tr>\n<td>IPO Close Date<\/td>\n<td>Oct 1, 2025<\/td>\n<\/tr>\n<tr>\n<td>Tentative Allotment<\/td>\n<td>Oct 3, 2025<\/td>\n<\/tr>\n<tr>\n<td>Initiation of Refunds<\/td>\n<td>Oct 6, 2025<\/td>\n<\/tr>\n<tr>\n<td>Credit of Shares to Demat<\/td>\n<td>Oct 6, 2025<\/td>\n<\/tr>\n<tr>\n<td>Tentative Listing Date<\/td>\n<td>Oct 7, 2025<\/td>\n<\/tr>\n<tr>\n<td>Cut-off time for UPI mandate confirmation<\/td>\n<td>5 PM on Oct 1, 2025<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Key_IPO_Details\"><\/span><strong>Key IPO Details:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Parameter<\/strong><\/td>\n<td><strong>Details<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Face Value<\/td>\n<td>\u20b910 per share<\/td>\n<\/tr>\n<tr>\n<td>Issue Price<\/td>\n<td>\u20b935 per share<\/td>\n<\/tr>\n<tr>\n<td>Lot Size<\/td>\n<td>4,000 shares<\/td>\n<\/tr>\n<tr>\n<td>Total Issue Size<\/td>\n<td>55,00,000\u00a0shares<br \/>\n(aggregating up to \u20b919.25\u00a0Cr)<\/td>\n<\/tr>\n<tr>\n<td>Reserved for\u00a0Market Maker<\/td>\n<td>2,84,000\u00a0shares<br \/>\n(aggregating up to \u20b90.9940\u00a0Cr)<\/p>\n<p>Shreni Shares Ltd.<\/td>\n<\/tr>\n<tr>\n<td>Net Offered to Public<\/td>\n<td>52,16,000\u00a0shares<br \/>\n(aggregating up to \u20b918.26\u00a0Cr)<\/td>\n<\/tr>\n<tr>\n<td>Sale Type<\/td>\n<td>Fresh Issue<\/td>\n<\/tr>\n<tr>\n<td>Issue Type<\/td>\n<td>Fixed Price IPO<\/td>\n<\/tr>\n<tr>\n<td>Listing At<\/td>\n<td>NSE SME<\/td>\n<\/tr>\n<tr>\n<td>Shareholding Pre-Issue<\/td>\n<td>1,40,28,686 shares<\/td>\n<\/tr>\n<tr>\n<td>Shareholding Post-Issue<\/td>\n<td>1,95,28,686 shares<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Investor_Category_Reservation\"><\/span><strong>Investor Category Reservation:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Investor Category<\/strong><\/td>\n<td><strong>Shares Offered<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Market Maker Shares Offered<\/td>\n<td>2,84,000 (5.16%)<\/td>\n<\/tr>\n<tr>\n<td>NII (HNI) Shares Offered<\/td>\n<td>26,08,000 (47.42%)<\/td>\n<\/tr>\n<tr>\n<td>Retail Shares Offered<\/td>\n<td>26,08,000 (47.42%)<\/td>\n<\/tr>\n<tr>\n<td>Total Shares Offered<\/td>\n<td>55,00,000 (100.00%)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Lot_Size_Investment\"><\/span><strong>Lot Size &amp; Investment:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Application<\/strong><\/td>\n<td><strong>Lots<\/strong><\/td>\n<td><strong>Shares<\/strong><\/td>\n<td><strong>Amount<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Retail (Min)<\/td>\n<td>2<\/td>\n<td>8,000<\/td>\n<td>\u20b92,80,000<\/td>\n<\/tr>\n<tr>\n<td>Retail (Max)<\/td>\n<td>2<\/td>\n<td>8,000<\/td>\n<td>\u20b92,80,000<\/td>\n<\/tr>\n<tr>\n<td>HNI (Min)<\/td>\n<td>3<\/td>\n<td>12,000<\/td>\n<td>\u20b94,20,000<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Promoter_Holding\"><\/span><strong>Promoter Holding:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The promoters of the company are Samit Madhukar Shah, Bhavin Dhirendra Shah, Rahul Dhirendra Shah, Narendra Nagindas Shah, Dina Madhukar Shah, and Hemanti Jitendra Shah.<\/p>\n<ul>\n<li>Pre-IPO: 78.30%<\/li>\n<li>Post-IPO: 56.25%<\/li>\n<\/ul>\n<p><strong>Book Running Lead Manager:<\/strong> Smart Horizon Capital Advisors Pvt. Ltd.<br \/>\n<strong>Registrar:<\/strong> <a href=\"https:\/\/www.torusdigital.com\/stocks\/kfin-technologies-ltd-share-price\">Kfin Technologies Ltd<\/a>.<br \/>\n<strong>Market Maker:<\/strong> Shreni Shares Ltd.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vijaypd_Ceutical_Ltd_Financials\"><\/span><strong>Vijaypd Ceutical Ltd.: Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Financial_Highlights_%E2%82%B9_Crore\"><\/span><strong>Financial Highlights (\u20b9 Crore):<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Period Ended<\/strong><\/td>\n<td><strong>31 Mar 2025<\/strong><\/td>\n<td><strong>31 Mar 2024<\/strong><\/td>\n<td><strong>31 Mar 2023<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Assets<\/td>\n<td>57.15<\/td>\n<td>33.27<\/td>\n<td>32.87<\/td>\n<\/tr>\n<tr>\n<td>Total Income<\/td>\n<td>107.59<\/td>\n<td>54.34<\/td>\n<td>50.59<\/td>\n<\/tr>\n<tr>\n<td>Profit After Tax<\/td>\n<td>4.80<\/td>\n<td>1.65<\/td>\n<td>0.18<\/td>\n<\/tr>\n<tr>\n<td>EBITDA<\/td>\n<td>8.59<\/td>\n<td>4.87<\/td>\n<td>1.32<\/td>\n<\/tr>\n<tr>\n<td>Net Worth<\/td>\n<td>32.17<\/td>\n<td>1.00<\/td>\n<td>4.93<\/td>\n<\/tr>\n<tr>\n<td>Reserves &amp; Surplus<\/td>\n<td>18.14<\/td>\n<td>&#8211;<\/td>\n<td>&#8211;<\/td>\n<\/tr>\n<tr>\n<td>Total Borrowing<\/td>\n<td>21.77<\/td>\n<td>30.04<\/td>\n<td>25.56<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Key_Performance_Indicators_FY2025\"><\/span><strong>Key Performance Indicators (FY2025):<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>KPI<\/strong><\/td>\n<td><strong>Value<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>ROE (Return on Equity)<\/strong><\/td>\n<td>28.91%<\/td>\n<\/tr>\n<tr>\n<td><strong>ROCE (Return on Capital Employed)<\/strong><\/td>\n<td>17.30%<\/td>\n<\/tr>\n<tr>\n<td><strong>Debt\/Equity<\/strong><\/td>\n<td>0.68<\/td>\n<\/tr>\n<tr>\n<td><strong>RoNW (Return on Net Worth)<\/strong><\/td>\n<td>14.91%<\/td>\n<\/tr>\n<tr>\n<td><strong>PAT Margin<\/strong><\/td>\n<td>4.49%<\/td>\n<\/tr>\n<tr>\n<td><strong>EBITDA Margin<\/strong><\/td>\n<td>8.04%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Vijaypd_Ceutical_IPO_Objectives\"><\/span><strong>Vijaypd Ceutical IPO Objectives<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The net proceeds from the IPO will be used for the following purposes:<\/p>\n<table>\n<thead>\n<tr>\n<td><strong>Object<\/strong><\/td>\n<td><strong>Amount (\u20b9 Crore)<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Funding Capital Expenditure for the pharmaceutical plant<\/td>\n<td>10.83<\/td>\n<\/tr>\n<tr>\n<td>Repayment\/prepayment of borrowings<\/td>\n<td>5.10<\/td>\n<\/tr>\n<tr>\n<td>General Corporate Purposes<\/td>\n<td>0.74<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Industry_Outlook\"><\/span><strong>Industry Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India\u2019s pharmaceutical sector continues to grow, driven by:<\/p>\n<ul>\n<li>Increasing demand for healthcare products, especially in the generics and wellness sectors<\/li>\n<li>Expanding healthcare infrastructure in both urban and rural regions<\/li>\n<li>Growing global presence of Indian pharmaceutical companies, driven by export opportunities<\/li>\n<\/ul>\n<p>Vijaypd Ceutical, with its established relationships and diverse portfolio, is well-positioned to leverage this growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vijaypd Ceutical Ltd. presents a valuable opportunity for investors seeking exposure to the pharmaceutical distribution space. With strong financial growth, a wide product range, and a robust distribution network, the company has significant potential. However, investors should consider risks like the dependence on key clients and fluctuations in pharmaceutical demand.<\/p>\n<p>If you are exploring more investment opportunities, check out our dedicated page on <a href=\"https:\/\/www.torusdigital.com\/ipo\/upcoming-ipo\">upcoming IPO<\/a> to stay updated on the latest market offerings.<\/p>\n<p><span data-contrast=\"auto\">\u202f\u202f\u202f\u202f\u202f<\/span>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=&#8221;share_rating&#8221;][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h6>Rate this article<\/h6>\n<!-- FeedbackWP Plugin --><div  class=\"rmp-widgets-container rmp-wp-plugin rmp-main-container js-rmp-widgets-container js-rmp-widgets-container--14481 \"  data-post-id=\"14481\">    <!-- Rating widget -->  <div class=\"rmp-rating-widget js-rmp-rating-widget\">            <div class=\"rmp-rating-widget__icons\">      <ul class=\"rmp-rating-widget__icons-list js-rmp-rating-icons-list\">                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Terrible!\" data-value=\"1\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star \"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Bad!\" data-value=\"2\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star \"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Okay!\" data-value=\"3\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star \"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Good!\" data-value=\"4\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star \"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Great!\" data-value=\"5\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star \"><\/i>          <\/li>              <\/ul>    <\/div>    <p class=\"rmp-rating-widget__hover-text js-rmp-hover-text\"><\/p>    <button class=\"rmp-rating-widget__submit-btn rmp-btn js-submit-rating-btn\">      Submit Rating    <\/button>    <p class=\"rmp-rating-widget__results js-rmp-results rmp-rating-widget__results--hidden\">       <span class=\"rmp-rating-widget__results__rating js-rmp-avg-rating\">0<\/span> \/ 5.  <span class=\"rmp-rating-widget__results__votes js-rmp-vote-count\">0<\/span>    <\/p>    <p class=\"rmp-rating-widget__not-rated js-rmp-not-rated \">          <\/p>    <p class=\"rmp-rating-widget__msg js-rmp-msg\"><\/p>  <\/div>  <!--Structured data -->        <\/div>\n<div id=\"emoji-overlay\" style=\"display: none;\">\n<div id=\"overlay-emoji\"><\/div>\n<div id=\"overlay-description\" class=\"emoji-text\"><\/div>\n<\/div>\n<div id=\"rating-popup\">\n<p><span id=\"popup-close\">\u00d7<\/span><\/p>\n<div class=\"popup_message\">\n<div id=\"popup-emoji\"><\/div>\n<div class=\"popup_innermsg\">\n<h5>Thank You for Rating Our Article!<\/h5>\n<p>Your feedback is incredibly valuable to us, and we&#8217;re thrilled to hear your thoughts.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h6>Share this article<\/h6>\n<div class=\"cscra-social square cscra-socials-679c8a1122c00\">\n        <a href=\"\/\/www.facebook.com\/sharer\/sharer.php?u=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fvijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss%2F&t=Vijaypd+Ceutical+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss\" class=\"facebook\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Facebook\" target=\"_blank\"><i class=\"fa fa-facebook\"><\/i><\/a>\n        <a href=\"\/\/twitter.com\/intent\/tweet?text=Vijaypd+Ceutical+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss&url=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fvijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss%2F\" class=\"twitter\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Twitter\" target=\"_blank\"><i class=\"fa-brands fa-x-twitter\"><\/i><\/a>\n        <a href=\"https:\/\/api.whatsapp.com\/send?text=Vijaypd+Ceutical+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss - https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fvijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss%2F\" class=\"whatsapp\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On WhatsApp\" target=\"_blank\"><i class=\"fa fa-whatsapp\"><\/i><\/a>\n        <a href=\"\/\/www.linkedin.com\/shareArticle?mini=true&url=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fvijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss%2F&title=Vijaypd+Ceutical+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss\" class=\"linkedin\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Linkedin\" target=\"_blank\"><i class=\"fa fa-linkedin\"><\/i><\/a>\n    <\/div>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][\/vc_section]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"[vc_section el_id=&#8221;blog-inner-layout&#8221;][vc_row overlay_dotted=&#8221;&#8221;][vc_column el_class=&#8221;blog_primary&#8221;][vc_row_inner][vc_column_inner][vc_column_text css=&#8221;&#8221;] India\u2019s IPO market continues to grow in 2025 with a variety of companies tapping into public funding. Among them, Vijaypd Ceutical Limited offers a promising investment opportunity in the pharmaceutical distribution sector. The company is all set to launch its IPO on September 29, 2025, with \u20b919.25 crore in fresh","protected":false},"author":1,"featured_media":14024,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[5,169],"tags":[],"class_list":["post-14481","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vijaypd Ceutical IPO Opens: Key Details Investors Must Know<\/title>\n<meta name=\"description\" content=\"Vijaypd Ceutical IPO provides an opportunity to invest in a leading pharmaceutical distributor with strong growth potential. Read on for all the details.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vijaypd Ceutical IPO Opens: Key Details Investors Must Know\" \/>\n<meta property=\"og:description\" content=\"Vijaypd Ceutical IPO provides an opportunity to invest in a leading pharmaceutical distributor with strong growth potential. Read on for all the details.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-26T07:11:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-26T08:04:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1441\" \/>\n\t<meta property=\"og:image:height\" content=\"466\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"torus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"torus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vijaypd Ceutical IPO Opens: Key Details Investors Must Know","description":"Vijaypd Ceutical IPO provides an opportunity to invest in a leading pharmaceutical distributor with strong growth potential. Read on for all the details.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/","og_locale":"en_US","og_type":"article","og_title":"Vijaypd Ceutical IPO Opens: Key Details Investors Must Know","og_description":"Vijaypd Ceutical IPO provides an opportunity to invest in a leading pharmaceutical distributor with strong growth potential. Read on for all the details.","og_url":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/","og_site_name":"Blog","article_published_time":"2025-09-26T07:11:25+00:00","article_modified_time":"2025-09-26T08:04:28+00:00","og_image":[{"width":1441,"height":466,"url":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","type":"image\/webp"}],"author":"torus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"torus","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/","url":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/","name":"Vijaypd Ceutical IPO Opens: Key Details Investors Must Know","isPartOf":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage"},"image":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","datePublished":"2025-09-26T07:11:25+00:00","dateModified":"2025-09-26T08:04:28+00:00","author":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/468d817c6d51cdd85d58071858a47ce5"},"description":"Vijaypd Ceutical IPO provides an opportunity to invest in a leading pharmaceutical distributor with strong growth potential. Read on for all the details.","breadcrumb":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage","url":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","contentUrl":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Essex-Marine-Ltd-IPO-1.webp","width":1441,"height":466},{"@type":"BreadcrumbList","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/vijaypd-ceutical-ipo-opens-key-details-investors-shouldnt-miss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Toruscope","item":"https:\/\/www.torusdigital.com\/toruscope\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.torusdigital.com\/toruscope\/.\/news\/"},{"@type":"ListItem","position":3,"name":"Vijaypd Ceutical IPO Opens: Key Details Investors Shouldn\u2019t Miss"}]},{"@type":"WebSite","@id":"https:\/\/www.torusdigital.com\/toruscope\/#website","url":"https:\/\/www.torusdigital.com\/toruscope\/","name":"Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.torusdigital.com\/toruscope\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/468d817c6d51cdd85d58071858a47ce5","name":"torus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/09645f2c6ef6bbb3a78db22600040d547bed4438a393e0671d168d69d193bc19?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/09645f2c6ef6bbb3a78db22600040d547bed4438a393e0671d168d69d193bc19?s=96&d=mm&r=g","caption":"torus"},"sameAs":["https:\/\/stage.torusdigital.com\/blogs"],"url":"https:\/\/www.torusdigital.com\/toruscope\/author\/torus\/"}]}},"_links":{"self":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/14481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/comments?post=14481"}],"version-history":[{"count":2,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/14481\/revisions"}],"predecessor-version":[{"id":14490,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/14481\/revisions\/14490"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/media\/14024"}],"wp:attachment":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/media?parent=14481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/categories?post=14481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/tags?post=14481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}